Refractory de novo myeloid sarcoma: a case report and therapeutic strategy based on bone marrow minimal residual disease

Int J Hematol. 2009 Jul;90(1):120-123. doi: 10.1007/s12185-009-0349-7. Epub 2009 Jun 10.

¹ Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan. [email protected].
² Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
³ Department of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.
⁴ Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
⁵ Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.

No abstract available

Publication types